您的位置: 首页 > 农业专利 > 详情页

ANTIBODY MOLECULES FOR CANCER TREATMENT
专利权人:
Boehringer Ingelheim International GmbH
发明人:
Markus ZETTL,Ivo LORENZ,Otmar SCHAFF,Melanie WURM,Jean-Francois FORTIN,Scott Ronald BRODEUR,Keith A. CANADA,Lukasz CHLEWICKI,Walter Carroll DAVIDSON,Pankaj GUPTA,Priyanka GUPTA,Rocío K. PÉREZ,Joseph R
申请号:
US15598356
公开号:
US20170334995A1
申请日:
2017.05.18
申请国别(地区):
US
年份:
2017
代理人:
摘要:
The present invention relates to novel anti-PD1 and anti-LAG3 antibody molecules. The invention also relates to nucleic acids encoding such antibody molecules; to methods for preparing such antibody molecules; to host cells expressing or capable of expressing such antibody molecules; to compositions comprising such antibody molecules; and to uses of such antibody molecules or such compositions, in particular for therapeutic purposes in the field of cancer diseases.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充